Considerable improvement in survival for patients aged 60–84 years with high grade malignant gliomas – Data from the Swedish Brain Tumour Population-based Registry-Reference-Cited by-同舟云学术

Considerable improvement in survival for patients aged 60–84 years with high grade malignant gliomas – Data from the Swedish Brain Tumour Population-based Registry

Published:2013-02-11 Issue:5 Volume:52 Page:1041-1043
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Asklund Thomas,Malmström Annika,Björ Ove,Blomquist Erik,Henriksson Roger

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2012.754993

Reference13 articles.

1. The 2007 WHO Classification of Tumours of the Central Nervous System

2. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

3. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

4. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

5. Survival of European patients with central nervous system tumors

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Cancer-Specific Survival of Brainstem Glioma in Children Based on Risk Stratification Model;Computational and Mathematical Methods in Medicine;2022-07-20

2. Sex Differences in Glioblastoma—Findings from the Swedish National Quality Registry for Primary Brain Tumors between 1999–2018;Journal of Clinical Medicine;2022-01-18

3. Glioblastoma with a primitive neuroectodermal component: two cases with implications for glioblastoma cell-of-origin;Clinical Imaging;2021-05

4. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma;Journal of Neuro-Oncology;2019-06-25

5. A Retrospective Evaluation of Bevacizumab Treatment in Patients with Progressive Malignant Glioma in Northern Sweden;Anticancer Research;2017-04-01